Bronchiolitis Obliterans Syndrome clinical trials

Explore recruiting bronchiolitis obliterans syndrome clinical trials.

Recruiting bronchiolitis obliterans syndrome studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Bronchiolitis Obliterans Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy of an anti-TSLP monoclonal antibody in the management of chronic bronchial disease induced by bronchiolitis obliterans syndrome in allogeneic hematopoietic stem cells transplantation recipients.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

An Open Label Follow-Up Study to Evaluate the Long Term Safety and Efficacy of L-CSA in Patients with a Diagnosis of CLAD-BOS after they have completed the participation to BOSTON 1 and BOSTON 2 studies

Spain, Germany, Austria, Belgium, Denmark, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

INCB 39110-801 A Phase 2, Open-Label, Multicenter, Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib (INCB039110)

Italy, Spain, Austria, Germany, Belgium, Greece

Therapeutic exploratory (Phase II) EU CTIS Study details

Bronchiolitis Obliterans Syndrome trials by city

Bronchiolitis Obliterans Syndrome in Toronto Bronchiolitis Obliterans Syndrome in Vancouver Bronchiolitis Obliterans Syndrome in Montreal Bronchiolitis Obliterans Syndrome in Calgary Bronchiolitis Obliterans Syndrome in Edmonton Bronchiolitis Obliterans Syndrome in Ottawa Bronchiolitis Obliterans Syndrome in Winnipeg Bronchiolitis Obliterans Syndrome in Quebec City Bronchiolitis Obliterans Syndrome in Hamilton Bronchiolitis Obliterans Syndrome in Kitchener Bronchiolitis Obliterans Syndrome in London Bronchiolitis Obliterans Syndrome in Halifax Bronchiolitis Obliterans Syndrome in New York Bronchiolitis Obliterans Syndrome in Los Angeles Bronchiolitis Obliterans Syndrome in Chicago Bronchiolitis Obliterans Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease